Student shoots dead female classmate after hugging her on university campus, later kills self

Mangaluru, May 24: Sleuths of Mangaluru North police station have arrested a fugitive who was on the run after being booked under the Arms Act in 2020.

Mangaluru Commissioner of Police Kuldeep Kumar R Jain said that the arrested man was identified as Nawaz Sharif alias Sharif from Valachil Adyar. 

He went to a Gulf country a year ago and failed to appear before the court. The court had issued warrants against him.

On getting credible information that he was in the Gulf, a lookout circular was issued. When he arrived at Mumbai International Airport, he was detained and handed over to the city police.

Mangaluru, May 16: Disheartened over his two consecutive defeats from Bantwal constituency in Karnataka Assembly polls, Congress leader and former minister B Ramanath Rai has announced his retirement from electoral politics.

Speaking to media persons in the city today, Mr Rai, however, clarified that he would continue to remain active in party activities.

“I am a 71-year-old and there was some disagreement in the party over my candidature. The party has given me all the opportunities all these years,” he said. “However, I will abide by the decision of the high command,” he added.

“I was confident of winning the election as the situation was favourable for the Congress. There was a setback somewhere and I will introspect on the reason for the defeat. Compared to the previous election, the victory margin of the BJP has come down to 8,282 votes from 15,971 votes, he said. 

To a query on whether he would contest the upcoming Lok Sabha election, Rai said “As I have decided, I will not contest the elections. The party is supreme for me and I will do whatever the high command wants me to do,” he added.

Lauding the party’s performance in the state, Rai said “BJP did not win a majority in the state all these years. They formed a coalition government with the JD(S) and later with the independent candidates and through ‘Operation Lotus’. The voters did not support the BJP. The BJP will never come to power again. The Congress will win even in the Lok Sabha elections,” he said and urged the party workers to get ready for the zilla panchayat, taluk panchayat and Lok Sabha elections. 

“We accept the defeat in the district but will work hard to gain back the seats as our party is in power in the state,” he said. “The Congress ‘Guarantees’ will be implemented soon after the oath-taking ceremony,” he said.

Tainted syrup medicine imported from India was the cause of an outbreak of kidney failure that killed more than 60 children in the West African nation of Gambia last year, according to a report by a team of international experts.

The report, submitted to the Gambian health ministry earlier this year and not yet made public, is the most definitive statement yet on the cause of the episode. It contradicts the official position of Indian authorities, who insist that the country’s products weren’t to blame. A director for the Gambian ministry of health didn’t respond to calls and an emailed request for comment.

Although the committee was able to establish that a child drank the contaminated medicine from an Indian drugmaker, Maiden Pharmaceuticals Ltd., in only 22 deaths from so-called acute kidney injury, or AKI, it said that symptoms in 30 others were consistent with the poison’s effects and no other cause could be found. It lacked enough information on 13 more cases. 

“The outbreak of AKI in children in the Gambia is attributable to medicines contaminated with DEG/EG,” the committee concluded, referring to the two contaminants, diethylene glycol and ethylene glycol.

Last year’s outbreak sparked concerns about the quality of generic medicine from India, an export powerhouse that calls itself the “pharmacy of the world.” Those concerns intensified this year when exported syrups from two other Indian manufacturers were found to be tainted in the same way, leading in one case to about 20 deaths in Uzbekistan.

“We have made our stand clear that as per our testing, the product had no issue,” said Rajeev Raghuvanshi, the Indian drug controller general, in a text message to Bloomberg. He referred further questions to the health ministry, which didn’t respond to requests for comment. A representative of Maiden also didn’t respond to inquiries.

India’s central government this week imposed a new regulation requiring cough syrup to be tested by a government lab before it can be exported.

Products from Maiden, a small New Delhi firm, fell under suspicion in Gambia last September, when health officials investigating the outbreak arranged tests of several drugs given to children prior to their deaths. Three labs in three different countries would eventually confirm the presence of the contaminants in Maiden products, the committee said in its report. 

The World Health Organization issued a public alert in October and Gambia recalled the drugs.

“After the poisonous medicines were withdrawn, there were no further cases,” said Kalle Hoppu, one of the committee members, in an email to Bloomberg. He called that “a very definitive sign that this outbreak was caused by these medicines.” Hoppu is a former director of the Poison Information Center at Helsinki University Hospital in Finland.

Indian authorities have defended the drugs. In December, the Indian drug controller general at the time, V.G. Somani, told the WHO that his organization’s own tests of Maiden drugs found no contamination. He went on to accuse the agency of acting on flimsy evidence and having “adversely impacted the image of Indian pharmaceutical products across the globe.” As recently as March, the Indian government said in a statement that the drugs weren’t tainted and didn’t kill anyone. 

Earlier reports by a Gambian parliamentary committee and by the U.S. Centers for Disease Control and Prevention both pointed to the Maiden drugs as the most plausible explanation for the outbreak. But the report by the 11-member expert committee was the first charged specifically with establishing the cause. 

The panel was set up by Gambia’s health ministry and consisted of five clinicians from local hospitals, two WHO officials, and four consultants from Senegal, Finland, and the UK. It was chaired by Abdou Niang, a nephrologist and professor at Cheikh Anta Diop University in Senegal. Members met for a week in December, and Hoppu said the report was submitted to the health ministry sometime around February. It’s unclear why the report has not been made public.

At the time the committee convened in December, Gambian authorities had logged 70 deaths of children suffering from AKI. Of those, the committee couldn’t get detailed information on 13, and it concluded that one death wasn’t consistent with AKI. That left 56 deaths that it examined in detail. The children in this group were about two years old on average, the committee report said.

In only four of the 56 cases did the committee find a possible alternative or contributing cause, such as Covid-19 or severe malaria. That left the 22 it tied to consumption of Maiden drugs, and 30 others where consumption of the drugs wasn’t established but the symptoms were consistent with exposure to the contaminants and no alternative cause was found. The report noted that parents can’t always recall the brand of medications they give their children.